Glyko Biomedical Overview
- Year Founded
-
1992
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
- Investments
-
2
Glyko Biomedical General Information
Description
Provider of biomedical research services. The company provides scientific research services regarding biotechnology and pharmaceuticals.
Contact Information
Website
www.glyko.comCorporate Office
- 371 Bel Marin Keys Boulevard
- Suite 210
- Novato, CA 94949
- United States
Corporate Office
- 371 Bel Marin Keys Boulevard
- Suite 210
- Novato, CA 94949
- United States
Glyko Biomedical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Glyko Biomedical Patents
Glyko Biomedical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-5283450-A | Fit-ccd image sensing device | Inactive | 15-Apr-1991 | ||
| CA-1233827-A | Halogenated hydantoins | Inactive | 11-Sep-1984 | ||
| CA-1214373-A | Agglomerated halo-hydantoins | Inactive | 18-Oct-1983 | ||
| US-4481038-A | Lubricant waxes | Inactive | 29-Jun-1983 | ||
| US-4363891-A | Glyceryl monostearate plastic lubricants | Inactive | 14-May-1981 | C08K5/103 |
Glyko Biomedical Investments (2)
Glyko Biomedical’s most recent deal was a PE Growth/Expansion with BioMarin Pharmaceutical for . The deal was made on 15-Jul-1998.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| BioMarin Pharmaceutical | 15-Jul-1998 | PE Growth/Expansion | Drug Discovery | ||
| BioMarin Pharmaceutical | 01-Mar-1997 | Seed Round | Drug Discovery |
Glyko Biomedical Exits (2)
Glyko Biomedical’s most recent exit was on 15-Jul-1998 from BioMarin Pharmaceutical. The exit was categorized as with 5 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| BioMarin Pharmaceutical | 15-Jul-1998 | Completed |
|
||
| BioMarin Pharmaceutical | 01-Mar-1997 | Seed Round | Completed |
|
Glyko Biomedical FAQs
-
When was Glyko Biomedical founded?
Glyko Biomedical was founded in 1992.
-
Where is Glyko Biomedical headquartered?
Glyko Biomedical is headquartered in Novato, CA.
-
What industry is Glyko Biomedical in?
Glyko Biomedical’s primary industry is Drug Discovery.
-
Is Glyko Biomedical a private or public company?
Glyko Biomedical is a Private company.
-
What is the current valuation of Glyko Biomedical?
The current valuation of Glyko Biomedical is .
-
What is Glyko Biomedical’s current revenue?
The current revenue for Glyko Biomedical is .
-
When was Glyko Biomedical acquired?
Glyko Biomedical was acquired on 22-Aug-2002.
-
Who acquired Glyko Biomedical?
Glyko Biomedical was acquired by BioMarin Pharmaceutical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process